Presseportal.ch - Intravacchttps://www.presseportal.ch/de/nr/100084277?langid=2Presseportal.ch: Intravacc (Newsroom)de-denews aktuell schweiz AGhttps://www.presseportal.ch/images/logos/logo-ch-250.jpgPresseportal.ch - Intravacchttps://www.presseportal.ch/de/nr/100084277?langid=2info@newsaktuell.ch (presseportal.ch)Thu, 16 Apr 2026 19:02:16 +0200Wed, 07 Apr 2021 09:53:49 +0200Intravacc6Intravacc announces positive preclinical data for its SARS-CoV-2 nose spray vaccineIntravacc: Bilthoven, Netherlands (ots/PRNewswire) - - Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2 - Intranasal vaccine administration has significant advantages over injectables - OMV technology is a powerful vaccine ...https://www.presseportal.ch/de/pm/100084277/100868360?langid=2Wed, 07 Apr 2021 09:53:49 +0200https://www.presseportal.ch/de/pm/100084277/100868360?langid=2 Intravacc [Newsroom]
Bilthoven, Netherlands (ots/PRNewswire) - - Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2 - Intranasal vaccine administration has significant advantages over injectables - OMV technology is a powerful vaccine ... Lesen Sie hier weiter...

]]>Wirtschaftinfo@newsaktuell.ch (presseportal.ch)Intravacc